Turkish Journal of Biology
Volume 36

Number 1

Article 1

1-1-2012

Prevalence of the IVS1(+1)G->A and 35delG mutations in the
GJB2 gene of Turkish patients with nonsyndromic hearing loss
TÜZÜN ARIK BIYIKLI

Follow this and additional works at: https://journals.tubitak.gov.tr/biology
Part of the Biology Commons

Recommended Citation
BIYIKLI, TÜZÜN ARIK (2012) "Prevalence of the IVS1(+1)G->A and 35delG mutations in the GJB2 gene of
Turkish patients with nonsyndromic hearing loss," Turkish Journal of Biology: Vol. 36: No. 1, Article 1.
https://doi.org/10.3906/biy-1012-174
Available at: https://journals.tubitak.gov.tr/biology/vol36/iss1/1

This Article is brought to you for free and open access by TÜBİTAK Academic Journals. It has been accepted for
inclusion in Turkish Journal of Biology by an authorized editor of TÜBİTAK Academic Journals. For more
information, please contact academic.publications@tubitak.gov.tr.

T. ARIK BIYIKLI
Turk J Biol
36 (2012) 1-6
© TÜBİTAK
doi:10.3906/biy-1012-174

Prevalence of the IVS1(+1)G→A and 35delG mutations in the
GJB2 gene of Turkish patients with nonsyndromic hearing loss
Tüzün ARIK BIYIKLI
Çağrıbey Anatolian High School, Ankara - TURKEY

Received: 23.12.2010

Abstract: GJB2 encodes connexin 26, a gap junction protein that is assumed to be a component of the potassium
recycling pathway in the inner ear. Loss or malfunction of these gap junctions, as might be reflected by mutations in
GJB2, may disrupt potassium movement from the hair cells through the supporting cell network to the endolymph,
leading to hearing impairment.
One mutation, the deletion of 1 guanosine residue from a stretch of 6 between nucleotide positions 30 and 35 (35delG)
at codon 10, is the most common deafness-causing allelic variant of GJB2 in sporadic patients and autosomal recessive
families. Mutations in the GJB2 gene represent the most common cause of autosomal recessive, sensorineural hearing
loss. The 35delG mutation accounts for more than two-thirds of identified mutations. In this study, mutations, especially
in the connexin 26 (GJB2), connexin 30 (GJB6), and 12srRNA genes, among 173 unrelated patients with prelingual
nonsyndromic autosomal recessive deafness were screened and investigated by using the polymerase chain reactionbased restriction fragment length polymorphism (PCR-based RFLP), single-strand conformation polymorphism
(SSCP), and sequence analysis methods. In patients with severe to profound hearing loss, 2 different mutations and 1
polymorphism (35delG and IVS1(+1)G→A mutations and V153I polymorphism) were found. The 35delG mutation was
detected as the most common pathogenic allele among the Turkish patients and accounted for 50% of all mutant GJB2
alleles. The 35delG and IVS1+1G→A mutations in the Cx26 gene were detected with total allele frequencies of 16.47%
and 4.33%, respectively, and the V153 polymorphism was found in a heterozygous state at an allele frequency of 3.47%.
However, the 342-kb deletion in the Cx30 gene and mitochondrial (mt)1555A→G in the 12srRNA gene mutations could
not be detected among the studied patients.
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Sendromik olmayan işitme kayıplı Türk hastaların GJB2 genindeki IVS1(+1)G→A ve
35delG mutasyonlarının yaygınlığı
Özet: GJB2, iç kulaktaki potasyum geri dönüşüm yolunun bir bileşeni olarak varsayılan koneksin 26, ara bağlantı
proteinini, kodlar. GJB2 genindeki mutasyonlar tarafından ortaya çıkan bu ara bağlantıların kayıp veya hasarı, tüy
hücrelerinden endolimfteki destek hücre bağlantısına doğru olan potasyum hareketini bozarak işitme kaybına yol açar.
Kodon 10’da 30-35. nükleotit pozisyonları arasındaki 6 guanin nükleotit dizisinden bir guanine nükleotidinin delesyonu
olan bir mutasyon, sporadik hastalar ve otozomal resesif ailelerde GJB2’nin alelik varyantlarına neden olan en yaygın
sağırlık sebebidir. GJB2 genindeki mutasyonlar otozomal resesif sensörinöral işitme kaybının en yaygın nedenlerinden
biridir. 35 del G mutasyonu, tanımlanan mutasyonların 2/3 oranından daha fazla oranda yer alır. Bu çalışma kapsamında
otozomal resesif, prelingual sendromik olmayan işitme kayıplı, birbirinden bağımsız 173 Türk hasta arasında özellikle
connexin 26 (GJB2) connexin 30 (GJB6) ve 12srRNA genlerindeki yaygın mutasyonlar, Polimeraz Zincir Reaksiyonu
Restriksiyon Parça Uzunluk Polimorfizmi (PZR-RFLP), SSCP ve dizi analiz yöntemleri ile araştırılmıştır. İki farklı
mutasyon ve bir polimorfizm, (35delG, IVS1+(1)G→A mutasyonları ve V153I polimorfizmi) şiddetli ve ağır tipte
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işitme kaybına sahip hastalarda bulunmuştur. 35delG mutasyonu Türk hastalarımız arasında en yaygın patojenik allel
olarak tespit edilmiştir ve tüm mutant GJB2 allellerin yaklaşık % 50’sinde yer almaktadır. Cx26 geninde 35delG ve
IVS1+1G→A mutasyonları sırasıyla % 16,47 ve % 4,33 toplam allel frekansıyla tespit edilmiştir. Hastalarımız arasında
V153 polimorfizmi % 3,47 allel frekansı ile heterozigot halde bulunmuştur. Diğer taraftan Cx30 genindeki 342-kb
delesyon ve 12 srRNA genindeki mitokondriyal (mt)1555A→G mutasyonları çalışılan hastalar arasında bulunamamıştır.
Anahtar sözcükler: GJB2, sendromik olmayan işitme kaybı, IVS1(+1)G→A, 35delG, V153I

Introduction
Congenital and early childhood hearing loss
of over 35 dB HL occurs in 1 out of every 1000
live births, and more than half of these cases are of
hereditary origin (1). Approximately 70%-80% of
genetic hearing loss is described as “nonsyndromic,”
as there are no other accompanying signs or
symptoms to suggest a syndrome. To date, around 100
nonsyndromic hearing loss (NSHL) loci have been
identified. Although the highest number of these loci
and the corresponding genes are responsible for a
dominant mode of inheritance, they constitute only
15%-20% of NSHL; the great majority of the NSHL
cases (75%-80%) are inherited in an autosomal
recessive fashion (1,2). Among the 37 known loci for
autosomal recessive (AR) NSHL, DFNB1 mapping
to chromosome 13q12 is by far the most prevalent.
This locus contains 2 gap junction genes, GJB2 and
GJB6, and encoding gap junction proteins, connexin
26 and connexin 30, respectively (2). Mutations in
GJB2 are estimated to be responsible for more than
50% of ARNSHL. More than 100 different mutations
of GJB2 have been identified (Hereditary Hearing
Loss Homepage at http://hereditaryhearingloss.
org/). One particular mutation, 35delG, accounts for
up to 70% of the pathological alleles in the European
and American Caucasian populations, as well as in
some other ethnic groups, with a carrier frequency
ranging from 1.2% to 3.5% (1,3). It is associated
with dominant and syndromic hearing loss, as well
(4). Previous studies confirmed that 35delG is also a
fairly common mutation among the Turkish hearingimpaired population (3,5-7).
In the present study, the GJB2 gene of 111 adult
Turkish patients between the ages of 19 and 28,
with congenital or early childhood deafness, and
62 deaf children between the ages of 5 and 15 years
from 2 schools for the deaf in Ankara, Turkey, were
examined in order to determine the molecular
pathology underlying deafness in these patients.
2

Materials and methods
Subjects
Our subjects consisted of 2 groups of hearingimpaired patients. The first group was selected from
among the male military conscripts, or candidate
conscripts, who were referred to the Mevki Military
Hospital ENT Department (Ankara) for evaluation
of fitness for obligatory military service. Of these, 111
consecutive patients between the ages of 19 and 28
with a bilateral prelingual hearing loss were included
in the study. A routine otoscopic examination and
tympanometry was carried out prior to pure tone
audiometry in all patients in order to detect any
otopathologies that might have caused or contributed
to the existing hearing loss. Hearing levels were
classified as mild (25-41 dB HL), moderate (41-56 dB
HL), moderately severe (56-71 dB HL), severe (7191 dB HL), and profound (over 91 dB HL) (8). The
patients also met the criteria of having no symptoms
or past medical history suggestive of intrauterine
infection, no history of neonatal and early childhood
infection or diseases that might have caused the
hearing impairment, and no history of head trauma
or cranial operation and no accompanying signs and
symptoms which indicate a syndromic hearing loss.
The second group was made up of 62 hearingimpaired children, ranging in age from 5 to 15
years, from 2 schools for the deaf in Ankara, again
in accordance with the above criteria. The hearing
impairment level of the children was either severe or
profound (over 71 dB HL).
For both groups, a thorough family history was
taken and the patients or parents were questioned
regarding the origin of the family, affected siblings
or any other kin, any consanguineous marriage in
the family, and any other inherited disease among
the family members. Each of the 173 subjects was
representative of 173 independent families.
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DNA studies
Having acquired informed consent for the
study from either the parents or the patients, DNA
was extracted from peripheral blood according to
standard procedures (9). Analysis of the common
35delG mutation was performed in all probands
by polymerase chain reaction-based restriction
fragment length polymorphism (PCR-based RFLP)
using MvaI (or BstNI) restriction endonuclease.
Samples heterozygous or negative for the 35delG
mutation were further screened for IVS1(+1)G→A,
167delT, and mitochondrial 1555A→G mutations by
PCR-based RFLP using BspMI (or BfuAI ), PstI, and
Alw26I restriction endonucleases, respectively. The
342-kb deletion in the Cx30 gene was also screened
in all subjects by a PCR-based assay as previously
described (5). The 35delG and IVS1(+1)G→A
mutations, determined by enzyme digestion, were
also confirmed by the dideoxy chain-termination
sequence reaction (10). The entire coding region of
patients that were heterozygous or did not have any
of the above mutations was analyzed by sequencing
or single-strand conformation polymorphism
(SSCP) to detect whether there was any other Cx26
gene mutation. For sequencing, the entire coding
region of exon 2 was amplified with the primers
Cx2F: 5’-GTGCATTCGTCTTTTCCAGAGCA-3’
and Cx2R: 5’-TTGACA GCTGAGCACGGGTTG-3’.
The resulting 794-bp PCR fragments were sequenced
using appropriate overlapping primers to cover the
entire exon 2 of the GJB2 gene. For SSCP analysis
(11), the coding exon was amplified using primers,
giving 4 overlapping segments of about 250 bp in
size. The resulting fragments were analyzed with 8%
nondenaturing polyacrylamide gel electrophoresis
(PAGE). The samples with a shifted band in the SSCP
analysis were sequenced and a G→A alteration at
nucleotide 457 (codon 153 Val→Ile) was found. This
region was analyzed in all of the samples by SSCP.
Since this mutation creates a cleavage site of the
enzyme Bsp14071, all subjects with the same shifted
band in SSCP were also confirmed by RFLP analysis
using the Bsp1407I enzyme.

Cx26 mutations tested, which were 35delG, IVS1(+1)
G→A, and V153I. The sequence results of the 35delG,
IVS1(+1)G→A, and V153I mutations are shown in
Figures 1, 2, and 3, respectively, and the frequencies
of these mutations among Turkish NSHL patients are
given in Table 1.
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Figure 1. DNA sequence results of 35delG.
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Results and discussion
A total of 34 cases in Group I and 18 cases in
Group II were found to be mutant for 1 or 2 of the 3
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Figure 2. DNA sequence results of IVS1(+1)G→A.
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The frequencies of these mutations in the study
group were 15.76% in Group I and 17.74% in Group
II for 35delG, 5.40% in Group I and 2.42% in Group
II for IVS1(+1)G→A, and 2.25% in Group I and
0.81% in Group II for V153I. The allele frequencies of
35delG, IVS1(+1)G→A, and V153I in the GJB2 gene
were 47.90%, 12.60%, and 5.04%, respectively.
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Figure 3. DNA sequence results of V153I mutation (nt 457
G→A).

As shown in Table 2, 11 patients in Group I
(9.91%) and 6 in Group II (9.68%) were found to be
homozygous for the 35delG mutation. Only 3 patients
(2.70%), all from Group I, were homozygous for
IVS1(+1)G→A, and 2 of these 3 patients had severe to
profound hearing loss. On the other hand, 4 patients
in Group I (3.60%) were compound heterozygous
for 35delG and IVS1(+1)G→A, and all but 1 of these
4 had milder hearing loss. In Group II, 2 patients
(3.22%) were found to be compound heterozygous
for 35delG and IVS1(+1)G→A.

Table 1. Allele frequencies of mutations and polymorphisms among Turkish patients with NSHL.

Mutant alleles
35delG

IVS1+1G>A

Val153I

342-kb del

mt1555 A>G

167delT

Group I

35/222 (15.76%)

12/222 (5.40%)

5/222 (2.25%)

0/222

0/222

0/222

Group II

22/124 (17.74 %)

3/124 (2.41%)

1/124 (0.80%)

0/124

0/124

0/124

Total

57/346 (16.47 %)

15/346 (4.33 %)

6/346 (1.73%)

0/346

0/346

0/346

Group

Table 2. Genotype frequencies of patients.

Genotype
35delG/35delG

35del/IVS1(+1)G®A

35delG/?

IVS1(+1)G®A/IVS1(+1)G®A

IVS1(+1)G®/?

V153I/?

Group I

11/111
(9.91%)

4/111
(3.60%)

9/111
(8.11%)

3/111
(2.70%)

2/111
(1.80%)

5/111
(4.50%)

Group II

6/62
(9.68%)

2/62
(3.22%)

8/62
(12.90%)

0/62
(0.00%)

1/62
(1.61%)

1/62
(1.61%)

Total

17/173
(9.83%)

6/173
(3.47%)

17/173
(9.83%)

3/173
(1.73%)

3/173
(1.73%)

6/173
(3.47%)

Group
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Sequence and/or SSCP analysis of 11 cases (8 from
Group I and 3 from Group II) that were negative for
the above mutations and 19 cases (13 from Group I
and 6 from Group II) that were heterozygote for 1
of these 3 mutations revealed that there were other
mutations in exon 2 of the GJB2 gene.
Although the complete coding region of the GJB2
gene was sequenced in cases with a heterozygous
35delG, IVS1(+1)G→A, or V153I mutation, a
mutation in the second allele could not be found.
Therefore, these patients and the patients who did not
carry any mutations in the GJB2 gene were tested for
the presence of the 342-kb deletion in the Cx30 gene
and for the 1555A>G mutation in 12srRNA. These
mutations were not found in any of these patients.
Since the first report by Kelsell et al. in 1997 (2),
there has been a plethora of reports implicating
mutations in the Cx26 gene as the major cause of
hereditary nonsyndromic sensorineural deafness.
The most prevalent of these mutations, 35delG, has
also been identified at an allele frequency of 20%30% in populations with ARNSHL in general, and
52%-90% in subjects with Cx26-related prelingual
deafness in different studies conducted on European
and American Caucasian populations (12-14). This
percentage drops drastically in Middle Eastern,
Asian, and African populations (15-18).
There have been several studies investigating the
prevalence of GJB2- and 35delG-related deafness
among Turkish hearing-impaired subjects, in which
the allele frequency of 35delG was reported to account
for 73% (3), 90% (5), and, in a smaller cohort, 64% (7)
of mutations in the GJB2 locus. Bayazıt et al. (2003),
however, found 35delG in only 40% of the alleles of
GJB2-related deafness in their Turkish subjects (6). In
another study by Tekin et al., the distribution of 35delG
was found at such a high heterogeneity throughout the
country that the prevalence varied between 5% and
50% from region to region (19). We found that the
35delG mutation accounted for 47.1% of the mutations
in the GJB2 gene, and the frequency of 35delG was
16.47% among our study group as a whole. In previous
studies, the homozygosity of the 35delG mutation was
reported as 19% in Turkish patients with ARNSHL
(20). This figure was 9.83% in our study groups. This
difference may be due to the large clinical heterogeneity
in our selected patients. Our subject families mostly

originated from central, southern, southeastern, and
northwestern Turkey. Although it was not statistically
analyzed, we could not note any significant variability
between regions in terms of 35delG prevalence,
contrary to the report of Tekin et al. (19).
One interesting finding, as an important outcome
of this study, is the existence of IVS1(+1)G→A, a splicesite mutation in the noncoding exon 1 of Cx26, among
Turkish hearing-impaired subjects at a significant
frequency. There are very few studies worldwide
reporting the identification of this particular mutation,
in which the allele frequency was found to be between
1% and 2.5% among Cx26 mutations (17). This
mutation was not reported in Turkish patients with
ARNSHL in previous studies. The frequency of 4.33%,
when both of our groups are combined, is also the
highest for IVS1(+1)G→A in the literature.
The V153I mutation has been alternatively
reported as either a polymorphism (6,21) or a
recessive pathogenic allele (22,23). Meşe et al., in 2004,
demonstrated that the V153I mutation was unable
to form functional channels in the paired Xenopus
oocyte expression system; their study thus supported
the view that V153I could be pathogenic (24). This
mutation was found in 5 patients in a heterozygous
state at a frequency of 4.91% in our study group. When
we screened this mutation in 90 individuals who had
no hearing impairment, we found that 6 individuals
(6.6%) were carrying this mutation in a heterozygous
state. These results support previous reports that this
alteration is a polymorphism rather than a mutation.
In summary, 35delG is the most common cause
of nonsyndromic genetic hearing loss among
Turkish deaf people. The phenotypes of Cx26-related
deafness are highly variable; however, according
to hearing threshold levels, 35delG mostly leads to
moderately severe or profound hearing loss, not only
in monogenic but also in digenic forms. Our results
also revealed that the IVS1(+1)G→A mutation is
found with a considerably high prevalence among
Turkish patients who are hearing impaired. Sequence
and SSCP analysis of the GJB2 gene in a total of 30
cases revealed that 34.45% of the GJB2 alleles did not
carry any mutation in the GJB2 gene. Therefore, there
must be another gene responsible for deafness in the
Turkish population.
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